Abstract

BackgroundPreterm infants are at risk for neurodevelopmental disorders, including motor, cognitive or behavioural problems, which may potentially be modified by early intervention. The EU CareToy Project Consortium (http://www.caretoy.eu) has developed a new modular system for intensive, individualized, home-based and family-centred early intervention, managed remotely by rehabilitation staff. A randomised controlled trial (RCT) has been designed to evaluate the efficacy of CareToy training in a first sample of low-risk preterm infants.Methods/DesignThe trial, randomised, multi-center, evaluator-blinded, parallel group controlled, is designed according to CONSORT Statement. Eligible subjects are infants born preterm without major complications, aged 3-9 months of corrected age with specific gross-motor abilities defined by Ages & Stages Questionnaire scores. Recruited infants, whose parents will sign a written informed consent for participation, will be randomized in CareToy training and control groups at baseline (T0). CareToy group will perform four weeks of personalized activities with the CareToy system, customized by the rehabilitation staff. The control group will continue standard care. Infant Motor Profile Scale is the primary outcome measure and a total sample size of 40 infants has been established. Bayley-Cognitive subscale, Alberta Infants Motor Scale and Teller Acuity Cards are secondary outcome measures. All measurements will be performed at T0 and at the end of training/control period (T1). For ethical reasons, after this first phase infants enrolled in the control group will perform the CareToy training, while the training group will continue standard care. At the end of open phase (T2) all infants will be assessed as at T1. Further assessment will be performed at 18 months corrected age (T3) to evaluate the long-term effects on neurodevelopmental outcome. Caregivers and rehabilitation staff will not be blinded whereas all the clinical assessments will be performed, videotaped and scored by blind assessors. The trial is ongoing and it is expected to be completed by April 2015.DiscussionThis paper describes RCT methodology to evaluate CareToy as a new tool for early intervention in preterm infants, first contribution to test this new type of system. It presents background, hypotheses, outcome measures and trial methodology.Trial registrationClinicalTrials.gov: NCT01990183. EU grant ICT-2011.5.1-287932.

Highlights

  • Preterm infants are at risk for neurodevelopmental disorders, including motor, cognitive or behavioural problems, which may potentially be modified by early intervention

  • This paper describes randomised controlled trial (RCT) methodology to evaluate CareToy as a new tool for early intervention in preterm infants, first contribution to test this new type of system

  • To test the effects of the CareToy training on infant’s neurodevelopment we propose a randomised controlled trial (RCT) in a population of low risk preterm infants

Read more

Summary

Discussion

The paper presents the background and the design for a RCT comparing a new intervention, CareToy Home, with the standard care for infants at low risk for neurodevelopmental disorders. The CareToy Home system represents a challenging and innovative tool in the field of infant rehabilitation This trial will explore the applicability of a new frontier of tele-medicine in infants. LB is senior clinical register at Pisa University Hospital (AOUP), Neonatology Unit and responsible of follow-up program. GC is specialist in child neuropsychiatry, full professor of child neuropsychiatry at University of Pisa and Scientific Director of IRCCS Fondazione Stella Maris. JBN is full professor of Neuroscience and head of the research section, Neural Control of Movement, at the Department of Neuroscience and Pharmacology and the Department of Nutrition, Exercise and Sport, University of Copenhagen. ES is senior paediatric physical therapist at IRCCS Fondazione Stella Maris

Background
Findings
12. Basu AP
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call